The Japanese Journal of Pharmacology · 1983 · 20 citations · 14 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyDopaminergic PharmacologyDrug ReceptorsNeurotransmitter ReceptorsReceptor PharmacologySerotonergic Pharmacology5-Hydroxytryptamine Receptor PharmacologyD2-like Dopamine ReceptorsDopamine D2-like ReceptorsDrug Receptor PharmacologyMonoamine ReceptorsMuscarinic Receptor PharmacologyReceptorsSerotonin Receptor Pharmacology
Effects of YM-09151-2 and five other neuroleptics (haloperidol, spiperone, chlorpromazine, sulpiride and clozapine) on the binding of [3H]-ligands to nine different receptors (α1,-adrenergic, α2-adrenergic. β-adrenergic, muscarinic, D2-dopaminergic, H1-histaminergic. 5HT1-serotonergic, 5HT2-serotonergic and opiate receptors) and on dopamine-sensitive adenylate cyclase were determined using brain membranes in the rat, guinea-pig and dog. The affinity of YM-09151-2 for D2-receptors with a Ki value of 0.1 nM was more than 1000-times higher than that for the other receptors and dopamine-sensitive adenylate cyclase, and it was the greatest among the nueroleptics tested.
14
André DeLÉAN, Peter J. Munson, David Rodbard · American Journal of Physiology-Endocrinology and Metabolism · 1978 · 2.4K citations